The purpose of this research study is to look at concentrations of GSK189075 in blood when different long and short acting forms of the drug are taken by mouth. The results will help to decide whether a long-acting form of GSK189075 can be made. The effects of the drug on the body and safety will also be studied.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
36
GSK Investigational Site
Columbus, Ohio, United States
Blood samples:
Time frame: collected over 24-hour period after each different form of GSK189075 given to measure amount of drug in blood
Urine:
Time frame: collected over 24-hour period after dosing with each form to measure amount of urine produced & amount of sugar in urine
Adverse events:
Time frame: all visits after Day -1
blood pressure & heart rate:
Time frame: screening,Day -1 - Day 1,follow-up visit
ECGs:
Time frame: screening,pre-dose, Day 1
lab tests:
Time frame: screening, Day -1 - Day 1,follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.